Holen Sie sich die Stockscreener-App
21.90
1.08%
0.0369
Schlusskurs vom Vortag:
$21.86
Offen:
$22.5
24-Stunden-Volumen:
1,173
Relative Volume:
0.22
Marktkapitalisierung:
$56.19M
Einnahmen:
$17,000
Nettoeinkommen (Verlust:
$-23.87M
KGV:
-7.0192
EPS:
-3.12
Netto-Cashflow:
$-22.03M
1W Leistung:
-2.17%
1M Leistung:
+11.84%
6M Leistung:
+17.74%
1J Leistung:
+61.43%
1-Tages-Spanne:
$20.25
$22.50
1-Wochen-Bereich:
$20.25
$23.05
52-Wochen-Spanne:
$12.62
$26.99
Vtv Therapeutics Inc Stock (VTVT) Company Profile
Firmenname
Vtv Therapeutics Inc
Sektor
Branche
Telefon
336-841-0300
Adresse
3980 PREMIER DR, HIGH POINT, NC
Vergleichen Sie VTVT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTVT
Vtv Therapeutics Inc
|
21.47 | 57.22M | 17,000 | -23.87M | -22.03M | -3.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.48 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
471.22 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.01 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
803.22 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
328.00 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-05-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-04-10 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2018-02-08 | Eingeleitet | Northland Capital | Outperform |
| 2016-09-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-09-04 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-08-24 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-08-24 | Eingeleitet | Stifel | Buy |
Alle ansehen
Vtv Therapeutics Inc Aktie (VTVT) Neueste Nachrichten
How vTv Therapeutics Inc. stock performs in rising dollar environment - newser.com
Can a trend reversal in vTv Therapeutics Inc. lead to recoveryPortfolio Gains Report & Consistent Income Trade Ideas - newser.com
Can vTv Therapeutics Inc. stock withstand economic slowdown2025 Winners & Losers & Daily Profit Focused Screening - newser.com
How cyclical is vTv Therapeutics Inc. (5VT0) stock compared to rivalsDip Buying & Long-Term Safe Investment Ideas - newser.com
Applying chart zones and confluence areas to vTv Therapeutics Inc.Inflation Watch & Free Risk Controlled Daily Trade Plans - newser.com
Strategies to average down on vTv Therapeutics Inc.Trade Risk Summary & Expert Curated Trade Setup Alerts - newser.com
Is vTv Therapeutics Inc. stock dividend yield sustainableWeekly Trend Recap & AI Driven Price Predictions - newser.com
Will vTv Therapeutics Inc. benefit from macro trendsQuarterly Profit Summary & High Win Rate Trade Tips - newser.com
Is vTv Therapeutics Inc. stock bottoming outWeekly Trade Report & Weekly Breakout Stock Alerts - newser.com
Tools to assess vTv Therapeutics Inc.’s risk profileProfit Target & Consistent Return Investment Signals - newser.com
Published on: 2025-10-10 04:14:14 - newser.com
vTv Therapeutics appoints four new members to scientific advisory board By Investing.com - Investing.com Nigeria
vTv Therapeutics (VTVT) Expands Scientific Advisory Board with N - GuruFocus
vTv Therapeutics appoints four new members to scientific advisory board - Investing.com
vTv Therapeutics Appoints Renowned Experts to Scientific Advisory Board for Cadisegliatin Development - Quiver Quantitative
vTv Therapeutics Announces New Appointments to its Scientific Advisory Board - GlobeNewswire
Visual analytics tools that track vTv Therapeutics Inc. performanceJuly 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com
Price action breakdown for vTv Therapeutics Inc.Trade Signal Summary & High Accuracy Trade Alerts - newser.com
Reviewing Repligen (NASDAQ:RGEN) and vTv Therapeutics (NASDAQ:VTVT) - Defense World
What drives vTv Therapeutics Inc stock pricePrice Action Trading & Outperform the Market with Aggressive Picks - earlytimes.in
Order flow analysis tools used on vTv Therapeutics Inc.July 2025 Final Week & Free Expert Approved Momentum Trade Ideas - newser.com
Published on: 2025-10-06 05:06:17 - newser.com
Will vTv Therapeutics Inc. (5VT0) stock deliver compounding returns2025 Bull vs Bear & Weekly Breakout Watchlists - newser.com
Can vTv Therapeutics Inc. (5VT0) stock withstand sector downturnsPortfolio Growth Summary & Growth-Oriented Investment Plans - newser.com
vTv Therapeutics Inc 5VT0 Stock Analysis and ForecastInterest Rate Changes & Affordable Trading Techniques - earlytimes.in
Published on: 2025-10-01 09:02:18 - newser.com
H.C. Wainwright Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $36 - 富途牛牛
What analysts say about vTv Therapeutics Inc stockCup and Handle Formations & High Yield Stock Picks - earlytimes.in
Is it time to cut losses on vTv Therapeutics Inc.July 2025 Analyst Calls & High Accuracy Swing Entry Alerts - newser.com
Multi asset correlation models including vTv Therapeutics Inc.2025 AllTime Highs & Risk Controlled Stock Alerts - newser.com
Is vTv Therapeutics Inc 5VT0 a good long term investmentVolatility Index Analysis & You’ll Thank Yourself in 6 Months - Early Times
vTv Therapeutics (NASDAQ:VTVT) Share Price Passes Above 50 Day Moving AverageTime to Sell? - MarketBeat
Will vTv Therapeutics Inc. rebound enough to break evenJuly 2025 PreEarnings & Weekly High Momentum Picks - newser.com
vTv Therapeutics Inc. recovery potential after sell offQuarterly Performance Summary & Low Risk High Win Rate Picks - newser.com
Multi factor analysis applied to vTv Therapeutics Inc.2025 Valuation Update & Weekly Breakout Watchlists - newser.com
Can swing trading help recover from vTv Therapeutics Inc. lossesLong Setup & Expert Approved Momentum Trade Ideas - newser.com
Published on: 2025-09-21 06:18:52 - newser.com
Finanzdaten der Vtv Therapeutics Inc-Aktie (VTVT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):